Iniciar sesión o Registrarse
Idioma
English
Русский
عربي
日本語
Deutsch
Français
Português
Español
简体中文
한국어
Turkish
Atrás
Home
About Us
Products
Services
News
Contact Us
Español
EnglishРусскийعربي日本語DeutschFrançaisPortuguêsEspañol简体中文한국어Turkish
Get Demo
Atrás
About XIHONG
Manufacturing and R&D
Dermal Filler
PLLA
CaHA
PLLA Pro
PCL
PMMA
More+
PosséiFill Skin Booster
Materials & Microspheres
Raw Materials
Biomedical microspheres
OEM & ODM
Licensing & Technology Transfer
Español
EnglishРусскийعربي日本語DeutschFrançaisPortuguêsEspañol简体中文한국어Turkish
Get Demo
Español
English Русский عربي 日本語 Deutsch Français Português Español 简体中文 한국어 Turkish
Get Demo
Inicio > Noticias
Categoría

Noticias

Xihong Biopharma’s Injectable Sodium Hyaluronate Composite Solution Receives Class III Approval from China’s NMPA

Xihong Biopharma’s Injectable Sodium Hyaluronate Composite Solution Receives Class III Approval from China’s NMPA
2025-12-11
The approved product is designed for Skin Booster, temporarily improving skin dryness and dullness in adults.
MORE DETAILS
Xihong Biopharma Showcases Full Regenerative Skin Booster and Dermal Filler Portfolio at AMWC Southeast Asia 2025, Attracting Strong Global Attention

Xihong Biopharma Showcases Full Regenerative Skin Booster and Dermal Filler Portfolio at AMWC Southeast Asia 2025, Attracting Strong Global Attention
2025-11-28
Xihong Biopharma successfully concluded its debut appearance at AMWC Southeast Asia 2025, one of the most influential medical aesthetics congresses in the ASEAN region.
MORE DETAILS
Xihong Obtains NMPA Class Ⅲ Medical Device Certificate for PLLA Microparticle Filler Injection

Xihong Obtains NMPA Class Ⅲ Medical Device Certificate for PLLA Microparticle Filler Injection
2025-07-16
The registration certificate of the Class Ⅲ medical device, Poly-L-lactic Acid Microparticle Filler Injection (the “Product”), has been approved by the National Medical Products Administration of China (NMPA), which marks a significant milestone for Xihong Biopharma in the regenerative product field, further expanding its consumer healthcare product portfolio.
MORE DETAILS
Xihong Biopharma and So Young Technology Form Deep Strategic Partnership to Shape the Future of Regenerative Medicine in Anti-Aging

Xihong Biopharma and So Young Technology Form Deep Strategic Partnership to Shape the Future of Regenerative Medicine in Anti-Aging
2023-07-06
The parties have entered into a 10-year exclusive master distribution agreement covering two advanced aesthetic products: the Sodium Hyaluronate Injectable Complex Solution and a new-generation Injectable PLLA Microsphere Facial Filler.
MORE DETAILS
Xihong Biopharma Grants Exclusive License to CMS for Injectable PLLA Filler

Xihong Biopharma Grants Exclusive License to CMS for Injectable PLLA Filler
2025-07-10
The injectable poly-L-lactic acid (PLLA) microsphere filler is classified as a Class III medical device and is currently undergoing registrational clinical trials in China. The product utilizes a patented microsphere fabrication process, resulting in uniformly shaped microspheres with even subcutaneous distribution and outstanding clinical performance.
MORE DETAILS
Xihong Biopharma Wraps Up a Successful Showcase at AMWC 2025 Monaco

Xihong Biopharma Wraps Up a Successful Showcase at AMWC 2025 Monaco
2025-03-29
Xihong Biopharma showcased its regenerative medicine solutions—combining advanced science, innovative manufacturing, and global partnerships. As a leading innovator from China, Xihong impressed attendees with its deep expertise and comprehensive portfolio in regenerative aesthetics.
MORE DETAILS
About Us
About Xihong
Manufacturing and R&D
OEM & ODM
Licensing & Technology Transfer
All Products
Dermal Filler
Materials & Microspheres
PLLA
CaHA
CONTACT
No. 20, Wenzhou Road, National Economic Development Zone, Shuyang, Suqian, Jiangsu Province
coop@dfyanmei.com
+8613310882353
Follow Us
Copyright © 2005-2025 MySite Ltd. All Rights Reserved. POWERED BY UEESHOP
Leave a message
First Name*
Last Name*
Email*
Message*